Recombinant factor viia for control of hemorrhage: early experience in critically ill trauma patients
- 20 May 2003
- journal article
- case report
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 15 (3) , 184-188
- https://doi.org/10.1016/s0952-8180(03)00034-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Potential role for rFVIIa in transfusion medicineTransfusion, 2002
- Recombinant Activated Factor VII for Adjunctive Hemorrhage Control in TraumaPublished by Wolters Kluwer Health ,2001
- An Effective Treatment of Severe Intractable Bleeding After Valve Repair by One Single Dose of Activated Recombinant Factor VIIAnesthesia & Analgesia, 2001
- REDUCED TRANSFUSION REQUIREMENTS BY RECOMBINANT FACTOR VIIa IN ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 2001
- Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate-related myocardial infarction in patients with haemophilia and inhibitorsBritish Journal of Haematology, 2000
- Treatment of traumatic bleeding with recombinant factor VIIaThe Lancet, 1999
- Epidemiology of Trauma DeathsThe Journal of Trauma: Injury, Infection, and Critical Care, 1995
- ‘DAMAGE CONTROL'Published by Wolters Kluwer Health ,1993
- Initiation and regulation of tissue factor-dependent blood coagulation.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusionThe American Journal of Surgery, 1990